Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MK-5046 is a novel BRS-3 agonist, binding to BRS-3 with high affinity (mouse Ki = 1.6 nM, human Ki = 25 nM).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 約4-6 週間 | ¥ 17,500 |
5 mg | 約4-6 週間 | ¥ 41,000 |
10 mg | 約4-6 週間 | ¥ 66,500 |
25 mg | 約4-6 週間 | ¥ 127,000 |
50 mg | 約4-6 週間 | ¥ 182,000 |
1 mL * 10 mM (in DMSO) | 約4-6 週間 | ¥ 45,500 |
説明 | MK-5046 is a novel BRS-3 agonist, binding to BRS-3 with high affinity (mouse Ki = 1.6 nM, human Ki = 25 nM). |
ターゲット&IC50 | BRS3 (mouse):1.6 nM (ki), BRS3 (human):25 nM(ki) |
分子量 | 444.37 |
分子式 | C20H18F6N4O |
CAS No. | 1022152-70-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mM
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MK-5046 1022152-70-0 GPCR/G Protein Bombesin Receptor inhibit MK5046 MK 5046 Inhibitor inhibitor